Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The New York Proton Center
Beijing Biotech
Parabilis Medicines, Inc.
Orano Med LLC
Filamon LTD
AstraZeneca
UMC Utrecht
Essen Biotech
Essen Biotech
Sapience Therapeutics
University of Nebraska
Adela, Inc